GLASS: Global Lorlatinib for ALK(+) and ROS1(+) Retrospective Study: Real World Data of 123 NSCLC Patients

Sadeleştirilmiş öğe sayfası
dc.contributor.authorPeled, N.
dc.contributor.authorGillis, R.
dc.contributor.authorKilickap, S.
dc.contributor.authorFroesch, P.
dc.contributor.authorOrlov, S.
dc.contributor.authorFilippova, E.
dc.contributor.authorDemirci, U.
dc.contributor.authorChristopoulos, P.
dc.contributor.authorCicin, I.
dc.contributor.authorBasal, F. Bugdayci
dc.contributor.authorYilmaz, C.
dc.contributor.authorFedor, M.
dc.contributor.authorKorkmaz, T.
dc.contributor.authorPaydas, S.
dc.contributor.authorGautschi, O.
dc.contributor.authorZirtiloglu, A.
dc.contributor.authorEralp, Y.
dc.contributor.authorCinkir, H. Y.
dc.contributor.authorSezer, A.
dc.contributor.authorErman, M.
dc.contributor.authorTural, D.
dc.contributor.authorTurna, H. Z.
dc.contributor.authorMazieres, J.
dc.contributor.authorDudnik, E.
dc.contributor.authorReguart, N.
dc.contributor.authorCamidge, R.
dc.contributor.authorNg, T. L.
dc.contributor.authorSenler, F. Cay
dc.contributor.authorBeypinar, I.
dc.contributor.authorYazilitas, D.
dc.contributor.authorDemirkazik, A.
dc.contributor.authorKaraoglu, A.
dc.contributor.authorOkutur, K.
dc.contributor.authorCoskun, H. Senol
dc.contributor.authorSendur, M. A. Nahit
dc.contributor.authorIsikdogan, A.
dc.contributor.authorCabuk, D.
dc.contributor.authorYumuk, P. F.
dc.contributor.authorYildiz, I.
dc.contributor.authorKaplan, M. A.
dc.contributor.authorOzyilkan, O.
dc.contributor.authorOztop, I.
dc.contributor.authorOlmez, O. F.
dc.contributor.authorAydin, K.
dc.contributor.authorAydiner, A.
dc.contributor.authorMeydan, N.
dc.contributor.authorGrinberg, R.
dc.contributor.authorRoisman, L.
dc.date.accessioned2025-10-16T15:19:41Z
dc.date.issued2021
dc.identifier.otherWOS:000631349602018
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/7386
dc.publisherELSEVIER SCIENCE INC
dc.sourceJOURNAL OF THORACIC ONCOLOGY
dc.subjectROS1\\(\\+\\)
dc.subjectALK\\(\\+\\)
dc.subjectlorlatinib
dc.titleGLASS: Global Lorlatinib for ALK(+) and ROS1(+) Retrospective Study: Real World Data of 123 NSCLC Patients
dc.typeMeeting Abstract

Dosyalar

Koleksiyonlar

WOS